Literature DB >> 27719647

Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natur a l Substitutes.

Mahmoud Bahmani1, Amir Sarrafchi2, Hedayatollah Shirzad2, Sedigheh Asgari3, Mahmoud Rafieian-Kopaei2.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of drugs which are used for a wide variety of diseases including pain and inflammatory conditions such as osteoarthritis, rheumatoid arthritis, musculoskeletal disorders, and other comorbid complications. However, this group of drugs have undesirable effects such as peptic ulcer, bleeding and renal failure. Some of these side effects are associated with or caused by generation of oxidative stress. Following the withdrawal of a cyclo-oxygenase-2 (COX-2) inhibitor drug, rofecoxib (VIOXX®) due to cardiovascular complications, scientists suggested that natural COX-2 inhibitors might provide valuable alternatives to COX inhibitors. Although, most of medicinal plants reduce pain and inflammation in a similar manner to synthetic medications, however, they often have fewer side effects and are better tolerated. The present review other than focusing on cardiovascular and some other complications of NSAIDs, is trying to introduce the natural alternative remedies for these medications. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  COX; Cardiovascular; NSAID; medicinal plants; oxidative stress; toxicity

Mesh:

Substances:

Year:  2017        PMID: 27719647     DOI: 10.2174/1381612822666161006144942

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  Analgesic Medicinal Plants in Shahrekord, Southwest of Iran: An Ethnobotanical Study.

Authors:  Gholam Basati; Saber Abbaszadeh; Arqavan Zebardast; Hassan Teimouri
Journal:  Galen Med J       Date:  2019-09-18

Review 2.  New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases.

Authors:  Wujun Chen; Yingjie Zhong; Nuan Feng; Zhu Guo; Shuai Wang; Dongming Xing
Journal:  Mol Med       Date:  2021-09-30       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.